Fernando Sumadhya Deepika, Navaratne Chathuri J, Galappaththy Gawrie Nl, Abeyasinghe Rabindra R, Silva Nilupa, Wickermasinghe Renu
Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Department of Parasitology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri Lanka.
J Glob Infect Dis. 2013 Oct;5(4):127-30. doi: 10.4103/0974-777X.121992.
With Sri Lanka aiming towards malaria elimination by 2015, the National Anti Malaria Campaign has stressed on the importance of identification of the species of Plasmodium either by examination of stained blood smears for malaria parasites or by Rapid Diagnostic Tests for malaria antigens before the initiation of treatment. This study aims at confirmation of the accuracy of clinical and/or microscopical malaria diagnosis using serology.
Study population comprised 51 individuals diagnosed with malaria either microscopically or clinically during the first half of 2011. ELISA for detection of the two significant blood antigens (AMA-1 and MSP1-19) was carried out in these individuals, 14-28 days after being diagnosed as being positive for malaria microscopically.
ELISA confirmed the microscopic diagnosis in all 47 of the patients including two mixed infections which flagged positive for both parasite antigens. However, four individuals diagnosed clinically as being positive for P. vivax by Health Care Providers were negative for malaria antibodies by ELISA.
With 175 cases of malaria reported in 2011, a formidable challenge exists to diagnose malaria positive blood smears due to the large number of negative blood smears being seen daily. After routine cross checking of positive slides, it is heartening to note that there were no false positives detected through serological assays amongst patients who were diagnosed as malaria positive by microscopy. Presumptive treatment of febrile patients with anti-malarials can lead to waste of resources and adversely impact the condition of the patient if the fever is not due to malaria.
随着斯里兰卡目标在2015年消除疟疾,国家抗疟运动强调在开始治疗前通过检查疟原虫染色血涂片或疟疾抗原快速诊断试验来鉴定疟原虫种类的重要性。本研究旨在通过血清学确认临床和/或显微镜疟疾诊断的准确性。
研究人群包括2011年上半年经显微镜或临床诊断为疟疾的51人。在这些人经显微镜诊断为疟疾阳性后的14 - 28天,进行酶联免疫吸附测定(ELISA)以检测两种重要的血液抗原(AMA - 1和MSP1 - 19)。
ELISA确认了所有47例患者的显微镜诊断,包括两例两种寄生虫抗原均呈阳性的混合感染。然而,医疗服务提供者临床诊断为间日疟原虫阳性的4人经ELISA检测疟疾抗体呈阴性。
2011年报告了175例疟疾病例,由于每天可见大量阴性血涂片,诊断疟疾阳性血涂片存在巨大挑战。在对阳性玻片进行常规交叉检查后,令人欣慰的是,在经显微镜诊断为疟疾阳性的患者中,通过血清学检测未发现假阳性。如果发热不是由疟疾引起,用抗疟药对发热患者进行推定治疗可能会导致资源浪费并对患者病情产生不利影响。